<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38259488</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.</ArticleTitle><Pagination><StartPage>1268510</StartPage><MedlinePgn>1268510</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1268510</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1268510</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although our understanding of the immunopathology and subsequent risk and severity of COVID-19 disease is evolving, a detailed account of immune responses that contribute to the long-term consequences of pulmonary complications in COVID-19 infection remains unclear. Few studies have detailed the immune and cytokine profiles associated with post-acute sequelae of SARS-CoV-2 infection (PASC) with persistent pulmonary symptoms. The dysregulation of the immune system that drives pulmonary sequelae in COVID-19 survivors and PASC sufferers remains largely unknown.</AbstractText><AbstractText Label="RESULTS">To characterize the immunological features of pulmonary PASC (PPASC), we performed droplet-based single-cell RNA sequencing (scRNA-seq) to study the transcriptomic profiles of peripheral blood mononuclear cells (PBMCs) from a participant na&#xef;ve to SARS-CoV-2 (Control) (n=1) and infected with SARS-CoV-2 with chronic pulmonary symptoms (PPASC) (n=2). After integrating scRNA-seq data with a na&#xef;ve participant from a published dataset, 11 distinct cell populations were identified based on the expression of canonical markers. The proportion of myeloid-lineage cells ([MLCs]; CD14<sup>+</sup>/CD16<sup>+</sup>monocytes, and dendritic cells) was increased in PPASC (n=2) compared to controls (n=2). MLCs from PPASC displayed up-regulation of genes associated with pulmonary symptoms/fibrosis, while glycolysis metabolism-related genes were downregulated. Similarly, pathway analysis showed that fibrosis-related (<i>VEGF</i>, <i>WNT</i>, and <i>SMAD</i>) and cell death pathways were up-regulated, but immune pathways were down-regulated in PPASC. Further comparison of PPASC with scRNA-seq data with Severe COVID-19 (n=4) data demonstrated enrichment of fibrotic transcriptional signatures. In PPASC, we observed interactive <i>VEGF</i> ligand-receptor pairs among MLCs, and network modules in CD14<sup>+</sup> (cluster 4) and CD16<sup>+</sup> (Cluster 5) monocytes displayed a significant enrichment for biological pathways linked to adverse COVID-19 outcomes, fibrosis, and angiogenesis. Further analysis revealed a distinct metabolic alteration in MLCs with a down-regulation of glycolysis/gluconeogenesis in PPASC compared to SARS-CoV-2 na&#xef;ve samples.</AbstractText><AbstractText Label="CONCLUSION">Analysis of a small scRNA-seq dataset demonstrated alterations in the immune response and cellular landscape in PPASC. The presence of elevated MLC levels and their corresponding gene signatures associated with fibrosis, immune response suppression, and altered metabolic states suggests a potential role in PPASC development.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Yoon, Dean, Jiyarom, Khadka, Deng, Nerurkar, Chow, Shikuma, Devendra, Koh and Park.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yoon</LastName><ForeName>Hyundong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dean</LastName><ForeName>Logan S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiyarom</LastName><ForeName>Boonyanudh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khadka</LastName><ForeName>Vedbar S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Bioinformatics Core, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Youping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bioinformatics Core, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nerurkar</LastName><ForeName>Vivek R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Dominic C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikuma</LastName><ForeName>Cecilia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devendra</LastName><ForeName>Gehan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, Queen's Medical Center, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Youngil</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Juwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, University of Hawai'i at M&#x101;noa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 MD007601</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM138062</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T37 MD008636</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM103466</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM139753</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Aug 02:2023.07.31.551349. doi: 10.1101/2023.07.31.551349</RefSource><PMID Version="1">37577518</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022423" MajorTopicYN="N">Myeloid Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="Y">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">monocyte</Keyword><Keyword MajorTopicYN="N">post-acute sequalae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">pulmonary sequelae</Keyword><Keyword MajorTopicYN="N">single-cell RNA sequencing</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>10</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38259488</ArticleId><ArticleId IdType="pmc">PMC10800799</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1268510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (Covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA (2020) 323(13):1239&#x2013;42. doi:&#xa0;10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina SK, Kumar R. Identifying role of public health and primary care as disparate entities in current health system. J Family Med Prim Care (2021) 10(10):3531&#x2013;4. doi:&#xa0;10.4103/jfmpc.jfmpc_1465_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1465_21</ArticleId><ArticleId IdType="pmc">PMC8653443</ArticleId><ArticleId IdType="pubmed">34934641</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow DL, Finelli L. Preparation for possible sustained transmission of 2019 novel Coronavirus: lessons from previous epidemics. JAMA (2020) 323(12):1129&#x2013;30. doi:&#xa0;10.1001/jama.2020.1960</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1960</ArticleId><ArticleId IdType="pubmed">32207807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilkington V, Keestra SM, Hill A. Global Covid-19 vaccine inequity: failures in the first year of distribution and potential solutions for the future. Front Public Health (2022) 10:821117. doi:&#xa0;10.3389/fpubh.2022.821117</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.821117</ArticleId><ArticleId IdType="pmc">PMC8936388</ArticleId><ArticleId IdType="pubmed">35321196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al. . Association between Mrna vaccination and Covid-19 hospitalization and disease severity. JAMA (2021) 326(20):2043&#x2013;54. doi:&#xa0;10.1001/jama.2021.19499</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.19499</ArticleId><ArticleId IdType="pmc">PMC8569602</ArticleId><ArticleId IdType="pubmed">34734975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed I, Nauman A, Paul P, Ganesan S, Chen KH, Jalil SMS, et al. . The efficacy and effectiveness of the Covid-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum Vaccin Immunother (2022) 18(1):2027160. doi:&#xa0;10.1080/21645515.2022.2027160</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2027160</ArticleId><ArticleId IdType="pmc">PMC8862168</ArticleId><ArticleId IdType="pubmed">35113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, et al. . Prevalence and correlates of long Covid symptoms among us adults. JAMA Netw Open (2022) 5(10):e2238804. doi:&#xa0;10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Tao M, Shang L, Liu Y, Pan G, Jin Y, et al. . Assessment of sequelae of Covid-19 nearly 1 year after diagnosis. Front Med (Lausanne) (2021) 8:717194. doi:&#xa0;10.3389/fmed.2021.717194</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.717194</ArticleId><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. . Short-term and long-term rates of postacute sequelae of Sars-Cov-2 infection: A systematic review. JAMA Netw Open (2021) 4(10):e2128568. doi:&#xa0;10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-Covid-19 condition. Annu Rev Med (2023) 74:55&#x2013;64. doi:&#xa0;10.1146/annurev-med-043021-030635</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute Covid-19 syndrome. Nat Med (2021) 27(4):601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long Covid: A cohort study. Lancet Diabetes Endocrinol (2022) 10(5):311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of Covid-19. Nat Med (2022) 28(3):583&#x2013;90. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long Covid. J Am Soc Nephrol (2021) 32(11):2851&#x2013;62. doi:&#xa0;10.1681/ASN.2021060734</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine (2023) 55:101762. doi:&#xa0;10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long CC. Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic Covid-19 in 2020 and 2021. JAMA (2022) 328(16):1604&#x2013;15. doi:&#xa0;10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (Covid-19) condition or long Covid: A meta-analysis and systematic review. J Infect Dis (2022) 226(9):1593&#x2013;607. doi:&#xa0;10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>McFann K, Baxter BA, LaVergne SM, Stromberg S, Berry K, Tipton M, et al. . Quality of life (Qol) is reduced in those with severe Covid-19 disease, post-acute sequelae of Covid-19, and hospitalization in United States adults from northern Colorado. Int J Environ Res Public Health (2021) 18(21):11048. doi:&#xa0;10.3390/ijerph182111048</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182111048</ArticleId><ArticleId IdType="pmc">PMC8582735</ArticleId><ArticleId IdType="pubmed">34769566</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R, Ali FM, Nixon SJ, Ingram JR, Salek SM, Finlay AY. Measuring the impact of Covid-19 on the quality of life of the survivors, partners and family members: A cross-sectional international online survey. BMJ Open (2021) 11(5):e047680. doi:&#xa0;10.1136/bmjopen-2020-047680</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-047680</ArticleId><ArticleId IdType="pmc">PMC8154981</ArticleId><ArticleId IdType="pubmed">34035105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak CR. The Health Impact of Long Covid: A Cross-Sectional Examination of Health-Related Quality of Life, Disability, and Health Status among Individuals with Self-Reported Post-Acute Sequelae of Sars Cov-2 Infection at Various Points of Recovery. J Patient Rep Outcomes (2023) 7(1):31. doi:&#xa0;10.1186/s41687-023-00572-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-023-00572-0</ArticleId><ArticleId IdType="pmc">PMC10029785</ArticleId><ArticleId IdType="pubmed">36943643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of Covid-19 at 2 years. Nat Med (2023) 29(9):2347&#x2013;57. doi:&#xa0;10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. . Risk factors associated with post-Covid-19 condition: A systematic review and meta-analysis. JAMA Intern Med (2023) 183(6):566&#x2013;580. doi:&#xa0;10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukkahatai N, Rodney T, Ling C, Daniel B, Han HR. Long Covid in the context of social determinants of health. Front Public Health (2023) 11:1098443. doi:&#xa0;10.3389/fpubh.2023.1098443</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1098443</ArticleId><ArticleId IdType="pmc">PMC10088562</ArticleId><ArticleId IdType="pubmed">37056649</ArticleId></ArticleIdList></Reference><Reference><Citation>Khullar D, Zhang Y, Zang C, Xu Z, Wang F, Weiner MG, et al. . Racial/ethnic disparities in post-acute sequelae of Sars-Cov-2 infection in New York: an Ehr-based cohort study from the recover program. J Gen Intern Med (2023) 38(5):1127&#x2013;36. doi:&#xa0;10.1007/s11606-022-07997-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07997-1</ArticleId><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of Covid-19 by severity of acute infection, demographics and health status. Nat Commun (2021) 12(1):6571. doi:&#xa0;10.1038/s41467-021-26513-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G, et al. . Female gender is associated with long Covid syndrome: A prospective cohort study. Clin Microbiol Infect (2022) 28(4):611 e9&#x2013; e16. doi:&#xa0;10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long Covid: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023) 21(3):133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. . Severity, predictors and clinical correlates of post-Covid syndrome (Pcs) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine (2022) 51:101549. doi:&#xa0;10.1016/j.eclinm.2022.101549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. . Long Covid Outcomes at One Year after Mild Sars-Cov-2 Infection: Nationwide Cohort Study. BMJ (2023) 380:e072529. doi:&#xa0;10.1136/bmj-2022-072529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ramasamy A, Verduzco-Gutierrez M, Brode WM, Melamed E. Acute and post-acute sequelae of Sars-Cov-2 infection: A review of risk factors and social determinants. Virol J (2023) 20(1):124. doi:&#xa0;10.1186/s12985-023-02061-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02061-8</ArticleId><ArticleId IdType="pmc">PMC10276420</ArticleId><ArticleId IdType="pubmed">37328773</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwahab N, Ingraham NE, Nguyen N, Siegel L, Silverman G, Sahoo HS, et al. . Predictors of postacute sequelae of Covid-19 development and rehabilitation: A retrospective study. Arch Phys Med Rehabil (2022) 103(10):2001&#x2013;8. doi:&#xa0;10.1016/j.apmr.2022.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9098397</ArticleId><ArticleId IdType="pubmed">35569640</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. . Factors associated with post-acute sequelae of Sars-Cov-2 (Pasc) after diagnosis of symptomatic Covid-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med (2022) 37(8):1988&#x2013;95. doi:&#xa0;10.1007/s11606-022-07523-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, et al. . Distinguishing features of long COVID identified through immune profiling. Nature (2023) 623:139&#x2013;48. doi:&#xa0;10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate Sars-Cov-2 infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Fang Z, De Souza CM, Lerbs T, Guan Y, Li I, et al. . Innate immune cell activation causes lung fibrosis in a humanized model of long Covid. Proc Natl Acad Sci U S A (2023) 120(10):e2217199120. doi:&#xa0;10.1073/pnas.2217199120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2217199120</ArticleId><ArticleId IdType="pmc">PMC10013740</ArticleId><ArticleId IdType="pubmed">36848564</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. . Immune signatures underlying post-acute Covid-19 lung sequelae. Sci Immunol (2021) 6(65):eabk1741. doi:&#xa0;10.1126/sciimmunol.abk1741</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodansky A, Wang C-Y, Saxena A, Mitchell A, Kung AF, Takahashi S, et al. . Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients. JCI Insight (2023) 8(11):e169515. doi:&#xa0;10.1172/jci.insight.169515</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.169515</ArticleId><ArticleId IdType="pmc">PMC10393220</ArticleId><ArticleId IdType="pubmed">37288661</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome Coronavirus 2 infection. J Infect Dis (2021) 224(11):1839&#x2013;48. doi:&#xa0;10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . The Il-1beta, Il-6, and Tnf cytokine triad is associated with post-acute sequelae of Covid-19. Cell Rep Med (2022) 3(6):100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Espin E, Yang C, Shannon CP, Assadian S, He D, Tebbutt SJ. Cellular and molecular biomarkers of long Covid: A scoping review. EBioMedicine (2023) 91:104552. doi:&#xa0;10.1016/j.ebiom.2023.104552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. . Covid-19 infection alters kynurenine and fatty acid metabolism, correlating with Il-6 levels and renal status. JCI Insight (2020) 5(14):e140327. doi:&#xa0;10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Feingold KR. The bidirectional link between Hdl and Covid-19 infections. J Lipid Res (2021) 62:100067. doi:&#xa0;10.1016/j.jlr.2021.100067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2021.100067</ArticleId><ArticleId IdType="pmc">PMC7963524</ArticleId><ArticleId IdType="pubmed">33741421</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer PE, Kirwan JP, Rosen CJ. Post-acute sequelae of Covid-19: A metabolic perspective. Elife (2022) 11. doi:&#xa0;10.7554/eLife.78200</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias SSG, Soares VC, Ferreira AC, Sacramento CQ, Fintelman-Rodrigues N, Temerozo JR, et al. . Lipid droplets fuel Sars-Cov-2 replication and production of inflammatory mediators. PloS Pathog (2020) 16(12):e1009127. doi:&#xa0;10.1371/journal.ppat.1009127</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009127</ArticleId><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardacci R, Colavita F, Castilletti C, Lapa D, Matusali G, Meschi S, et al. . Evidences for lipid involvement in Sars-Cov-2 cytopathogenesis. Cell Death Dis (2021) 12(3):263. doi:&#xa0;10.1038/s41419-021-03527-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03527-9</ArticleId><ArticleId IdType="pmc">PMC7952828</ArticleId><ArticleId IdType="pubmed">33712574</ArticleId></ArticleIdList></Reference><Reference><Citation>Grootemaat AE, van der Niet S, Scholl ER, Roos E, Schurink B, Bugiani M, et al. . Lipid and nucleocapsid N-protein accumulation in Covid-19 patient lung and infected cells. Microbiol Spectr (2022) 10(1):e0127121. doi:&#xa0;10.1128/spectrum.01271-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01271-21</ArticleId><ArticleId IdType="pmc">PMC8849100</ArticleId><ArticleId IdType="pubmed">35171025</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. . Elevated glucose levels favor Sars-Cov-2 Infection and Monocyte Response through a Hif-1alpha/glycolysis-dependent axis. Cell Metab (2020) 32(3):437&#x2013;46.e5. doi:&#xa0;10.1016/j.cmet.2020.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurshaney S, Morales-Alvarez A, Ezhakunnel K, Manalo A, Huynh TH, Abe JI, et al. . Metabolic dysregulation impairs lymphocyte function during severe Sars-Cov-2 infection. Commun Biol (2023) 6(1):374. doi:&#xa0;10.1038/s42003-023-04730-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04730-4</ArticleId><ArticleId IdType="pmc">PMC10080180</ArticleId><ArticleId IdType="pubmed">37029220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, et al. . A multi-omics based anti-inflammatory immune signature characterizes long Covid-19 syndrome. iScience (2023) 26(1):105717. doi:&#xa0;10.1016/j.isci.2022.105717</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. . Evolution of antibody immunity to Sars-Cov-2. Nature (2021) 591(7851):639&#x2013;44. doi:&#xa0;10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. . Sars-Cov-2 infection and persistence in the human body and brain at autopsy. Nature (2022) 612(7941):758&#x2013;63. doi:&#xa0;10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, et al. . Persistence of Sars Cov-2 S1 protein in Cd16+ Monocytes in post-acute sequelae of Covid-19 (Pasc) up to 15 months post-infection. Front Immunol (2021) 12:746021. doi:&#xa0;10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohn LB, Chomont N, Deeks SG. The biology of the Hiv-1 latent reservoir and implications for cure strategies. Cell Host Microbe (2020) 27(4):519&#x2013;30. doi:&#xa0;10.1016/j.chom.2020.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.03.014</ArticleId><ArticleId IdType="pmc">PMC7219958</ArticleId><ArticleId IdType="pubmed">32272077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendricks CM, Cordeiro T, Gomes AP, Stevenson M. The interplay of Hiv-1 and macrophages in viral persistence. Front Microbiol (2021) 12:646447. doi:&#xa0;10.3389/fmicb.2021.646447</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.646447</ArticleId><ArticleId IdType="pmc">PMC8058371</ArticleId><ArticleId IdType="pubmed">33897659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VH, Nordin JML, Nguyen S, Joy J, Mampe F, Del Rio Estrada PM, et al. . Profound phenotypic and epigenetic heterogeneity of the Hiv-1-infected Cd4(+) T cell reservoir. Nat Immunol (2023) 24(2):359&#x2013;70. doi:&#xa0;10.1038/s41590-022-01371-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01371-3</ArticleId><ArticleId IdType="pmc">PMC9892009</ArticleId><ArticleId IdType="pubmed">36536105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after Sars-Cov-2 infection. BMC Med (2022) 20(1):26. doi:&#xa0;10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute Covid-19 sequelae. Cell (2022) 185(5):881&#x2013;95.e20. doi:&#xa0;10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al. . 2017 Ers/Ats standards for single-breath carbon monoxide uptake in the lung. Eur Respir J (2017) 49(1):1600016. doi:&#xa0;10.1183/13993003.00016-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00016-2016</ArticleId><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. . Massively parallel digital transcriptional profiling of single cells. Nat Commun (2017) 8:14049. doi:&#xa0;10.1038/ncomms14049</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14049</ArticleId><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. . Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods (2019) 16(12):1289&#x2013;96. doi:&#xa0;10.1038/s41592-019-0619-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0619-0</ArticleId><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, et al. . Immunophenotyping of Covid-19 and influenza highlights the role of type I interferons in development of severe Covid-19. Sci Immunol (2020) 5(49). doi:&#xa0;10.1126/sciimmunol.abd1554</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd1554</ArticleId><ArticleId IdType="pmc">PMC7402635</ArticleId><ArticleId IdType="pubmed">32651212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lun ATL, Riesenfeld S, Andrews T, Dao TP, Gomes T, participants in the 1st Human Cell Atlas J et al. . Emptydrops: distinguishing cells from empty droplets in droplet-based single-cell Rna sequencing data. Genome Biol (2019) 20(1):63. doi:&#xa0;10.1186/s13059-019-1662-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1662-y</ArticleId><ArticleId IdType="pmc">PMC6431044</ArticleId><ArticleId IdType="pubmed">30902100</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ, Campbell KR, Lun AT, Wills QF. Scater: pre-processing, quality control, normalization and visualization of single-cell Rna-seq data in R. Bioinformatics (2017) 33(8):1179&#x2013;86. doi:&#xa0;10.1093/bioinformatics/btw777</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw777</ArticleId><ArticleId IdType="pmc">PMC5408845</ArticleId><ArticleId IdType="pubmed">28088763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. . Cellmarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on Scrna-seq data. Nucleic Acids Res (2023) 51(D1):D870&#x2013;D6. doi:&#xa0;10.1093/nar/gkac947</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac947</ArticleId><ArticleId IdType="pmc">PMC9825416</ArticleId><ArticleId IdType="pubmed">36300619</ArticleId></ArticleIdList></Reference><Reference><Citation>Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, et al. . Mast: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell Rna sequencing data. Genome Biol (2015) 16:278. doi:&#xa0;10.1186/s13059-015-0844-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0844-5</ArticleId><ArticleId IdType="pmc">PMC4676162</ArticleId><ArticleId IdType="pubmed">26653891</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (Msigdb) 3.0. Bioinformatics (2011) 27(12):1739&#x2013;40. doi:&#xa0;10.1093/bioinformatics/btr260</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr260</ArticleId><ArticleId IdType="pmc">PMC3106198</ArticleId><ArticleId IdType="pubmed">21546393</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng R, Zhang Y, Tsuji T, Zhang L, Tseng Y-H, Chen K. Mebocost: metabolic cell-cell communication modeling by single cell transcriptome. bioRxiv (2022). doi:&#xa0;10.1101/2022.05.30.494067</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.30.494067</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res (2019) 29(8):1363&#x2013;75. doi:&#xa0;10.1101/gr.240663.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.240663.118</ArticleId><ArticleId IdType="pmc">PMC6673718</ArticleId><ArticleId IdType="pubmed">31340985</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez MJ, Shen Y, Giorgi FM, Lachmann A, Ding BB, Ye BH, et al. . Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat Genet (2016) 48(8):838&#x2013;47. doi:&#xa0;10.1038/ng.3593</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3593</ArticleId><ArticleId IdType="pmc">PMC5040167</ArticleId><ArticleId IdType="pubmed">27322546</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. . Inference and analysis of cell-cell communication using cellchat. Nat Commun (2021) 12(1):1088. doi:&#xa0;10.1038/s41467-021-21246-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21246-9</ArticleId><ArticleId IdType="pmc">PMC7889871</ArticleId><ArticleId IdType="pubmed">33597522</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. Edger: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2010) 26(1):139&#x2013;40. doi:&#xa0;10.1093/bioinformatics/btp616</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Reports Methods (2022) 3(6):100498. doi:&#xa0;10.1101/2022.09.22.509094</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.22.509094</ArticleId><ArticleId IdType="pmc">PMC10326379</ArticleId><ArticleId IdType="pubmed">37426759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. . Enrichr: interactive and collaborative html5 gene list enrichment analysis tool. BMC Bioinf (2013) 14:128. doi:&#xa0;10.1186/1471-2105-14-128</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner A, Wang C, Fessler J, DeTomaso D, Avila-Pacheco J, Kaminski J, et al. . Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell (2021) 184(16):4168&#x2013;85.e21. doi:&#xa0;10.1016/j.cell.2021.05.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.045</ArticleId><ArticleId IdType="pmc">PMC8621950</ArticleId><ArticleId IdType="pubmed">34216539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, et al. . Hmdb 5.0: the human metabolome database for 2022. Nucleic Acids Res (2022) 50(D1):D622&#x2013;D31. doi:&#xa0;10.1093/nar/gkab1062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1062</ArticleId><ArticleId IdType="pmc">PMC8728138</ArticleId><ArticleId IdType="pubmed">34986597</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Dean LS, Jiyarom B, Gangcuangco LM, Shah P, Awamura T, et al. . Elevated circulating monocytes and monocyte activation in Covid-19 convalescent individuals. Front Immunol (2023) 14:1151780. doi:&#xa0;10.3389/fimmu.2023.1151780</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="pubmed">37077911</ArticleId></ArticleIdList></Reference><Reference><Citation>Thyagarajan B, Wojczynski M, Minster RL, Sanders J, Barral S, Christiansen L, et al. . Genetic variants associated with lung function: the long life family study. Respir Res (2014) 15(1):134. doi:&#xa0;10.1186/s12931-014-0134-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-014-0134-x</ArticleId><ArticleId IdType="pmc">PMC4228089</ArticleId><ArticleId IdType="pubmed">25409777</ArticleId></ArticleIdList></Reference><Reference><Citation>Atamas SP. Vascular endothelial growth factor in idiopathic pulmonary fibrosis. An imbalancing act. Am J Respir Crit Care Med (2017) 196(4):409&#x2013;11. doi:&#xa0;10.1164/rccm.201703-0605ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201703-0605ED</ArticleId><ArticleId IdType="pubmed">28809513</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein Shochet G, Bardenstein-Wald B, McElroy M, Kukuy A, Surber M, Edelstein E, et al. . Hypoxia inducible factor 1a supports a pro-fibrotic phenotype loop in idiopathic pulmonary fibrosis. Int J Mol Sci (2021) 22(7):3331. doi:&#xa0;10.3390/ijms22073331</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073331</ArticleId><ArticleId IdType="pmc">PMC8078165</ArticleId><ArticleId IdType="pubmed">33805152</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths K, Habiel DM, Jaffar J, Binder U, Darby WG, Hosking CG, et al. . Anti-fibrotic effects of cxcr4-targeting I-body ad-114 in preclinical models of pulmonary fibrosis. Sci Rep (2018) 8(1):3212. doi:&#xa0;10.1038/s41598-018-20811-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20811-5</ArticleId><ArticleId IdType="pmc">PMC5816662</ArticleId><ArticleId IdType="pubmed">29453386</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi N, Watanabe S, Verma R, Jablonski RP, Chen CI, Cheresh P, et al. . A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-Csf/M-Csfr signalling in monocyte-derived alveolar macrophages. Eur Respir J (2020) 55(1):1900646. doi:&#xa0;10.1183/13993003.00646-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00646-2019</ArticleId><ArticleId IdType="pmc">PMC6962769</ArticleId><ArticleId IdType="pubmed">31601718</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LC, Gao J, Li J. Emerging role of hmgb1 in fibrotic diseases. J Cell Mol Med (2014) 18(12):2331&#x2013;9. doi:&#xa0;10.1111/jcmm.12419</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12419</ArticleId><ArticleId IdType="pmc">PMC4302638</ArticleId><ArticleId IdType="pubmed">25284457</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Lu FA, Wang L, Wang YF, Wu CF. Long non&#x2212;Coding Rna neat1 promotes pulmonary fibrosis by regulating the microrna&#x2212;455&#x2212;3p/Smad3 axis. Mol Med Rep (2021) 23(3):218. doi:&#xa0;10.3892/mmr.2021.11857</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.11857</ArticleId><ArticleId IdType="pmc">PMC7845585</ArticleId><ArticleId IdType="pubmed">33495816</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurman AL, Li X, Villacreses R, Yu W, Gong H, Mather SE, et al. . A single-cell atlas of large and small airways at birth in a porcine model of cystic fibrosis. Am J Respir Cell Mol Biol (2022) 66(6):612&#x2013;22. doi:&#xa0;10.1165/rcmb.2021-0499OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2021-0499OC</ArticleId><ArticleId IdType="pmc">PMC9163647</ArticleId><ArticleId IdType="pubmed">35235762</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JL, Oviedo SA, Ali MK, Ofotokun I, Gander JC, Patel SA, et al. . The bidirectional association between diabetes and long-Covid-19 - a systematic review. Diabetes Res Clin Pract (2023) 195:110202. doi:&#xa0;10.1016/j.diabres.2022.110202</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamp JC, Werlein C, Plucinski EKJ, Neubert L, Welte T, Lee PD, et al. . Novel insight into pulmonary fibrosis and long Covid. Am J Respir Crit Care Med (2023) 207(8):1105&#x2013;7. doi:&#xa0;10.1164/rccm.202212-2314LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202212-2314LE</ArticleId><ArticleId IdType="pmc">PMC10112435</ArticleId><ArticleId IdType="pubmed">36731065</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamp JC, Neubert L, Ackermann M, Stark H, Werlein C, Fuge J, et al. . Time-dependent molecular motifs of pulmonary fibrogenesis in Covid-19. Int J Mol Sci (2022) 23(3):1583. doi:&#xa0;10.3390/ijms23031583</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031583</ArticleId><ArticleId IdType="pmc">PMC8835897</ArticleId><ArticleId IdType="pubmed">35163504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean LS, Chow DC, Ndhlovu LC, Boisvert WA, Chang SP, Shikuma CM, et al. . Characterization of circulating fibrocytes in people living with Hiv on stable antiretroviral therapy. Immunohorizons (2022) 6(11):760&#x2013;7. doi:&#xa0;10.4049/immunohorizons.2200085</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2200085</ArticleId><ArticleId IdType="pmc">PMC10402248</ArticleId><ArticleId IdType="pubmed">36445359</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. . Circulating fibrocytes traffic to the lungs in response to Cxcl12 and mediate fibrosis. J Clin Invest (2004) 114(3):438&#x2013;46. doi:&#xa0;10.1172/JCI20997</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI20997</ArticleId><ArticleId IdType="pmc">PMC484979</ArticleId><ArticleId IdType="pubmed">15286810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary NI, Roth GJ, Hilberg F, Muller-Quernheim J, Prasse A, Zissel G, et al. . Inhibition of pdgf, vegf and fgf signalling attenuates fibrosis. Eur Respir J (2007) 29(5):976&#x2013;85. doi:&#xa0;10.1183/09031936.00152106</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00152106</ArticleId><ArticleId IdType="pubmed">17301095</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschner Y, Downey GP. Transforming growth factor-Beta: master regulator of the respiratory system in health and disease. Am J Respir Cell Mol Biol (2016) 54(5):647&#x2013;55. doi:&#xa0;10.1165/rcmb.2015-0391TR</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2015-0391TR</ArticleId><ArticleId IdType="pmc">PMC4942197</ArticleId><ArticleId IdType="pubmed">26796672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Tam H, Adler L, Ilstad-Minnihan A, Macaubas C, Mellins ED. The Mhc class ii antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS One (2017) 12(8):e0183594. doi:&#xa0;10.1371/journal.pone.0183594</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183594</ArticleId><ArticleId IdType="pmc">PMC5568224</ArticleId><ArticleId IdType="pubmed">28832681</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI, et al. . Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of Covid-19 (Pasc). Metabolites (2022) 12(11):1026. doi:&#xa0;10.3390/metabo12111026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Meyers A, Long D, Ingram B, Liu T, Yoza BK, et al. . Frontline science: monocytes sequentially rewire metabolism and bioenergetics during an acute inflammatory response. J Leukoc Biol (2019) 105(2):215&#x2013;28. doi:&#xa0;10.1002/JLB.3HI0918-373R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3HI0918-373R</ArticleId><ArticleId IdType="pmc">PMC6466628</ArticleId><ArticleId IdType="pubmed">30633362</ArticleId></ArticleIdList></Reference><Reference><Citation>Stunault MI, Bories G, Guinamard RR, Ivanov S. Metabolism plays a key role during macrophage activation. Mediators Inflammation (2018) 2018:2426138. doi:&#xa0;10.1155/2018/2426138</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2426138</ArticleId><ArticleId IdType="pmc">PMC6311794</ArticleId><ArticleId IdType="pubmed">30647530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>